| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 345,177 | 336,835 | 339,755 | 352,805 | | Cost of Revenue | 70,035 | 65,019 | 65,424 | 66,868 | | | Gross Profit | 275,142 | 271,816 | 274,331 | 285,937 | | | Operating Expenses | | Research Development | 104,989 | 102,996 | 97,807 | 102,564 | | Selling General and Administrative | 105,708 | 111,211 | 104,566 | 115,034 | | Non Recurring | 400 |
-
| 600 |
-
| | Others | 2,956 | 2,941 | 3,786 | 3,035 | | | | Total Operating Expenses | 214,053 |
-
| 206,759 |
-
| | | | Operating Income or Loss | 61,089 | 54,668 | 67,572 | 65,304 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,384 | 10,445 | 2,099 | (9,584) | | Earnings Before Interest And Taxes | 66,473 | 65,113 | 69,671 | 55,720 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 66,473 | 65,113 | 69,671 | 55,720 | | Income Tax Expense | 19,037 | 16,825 | 17,242 | 9,323 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 47,436 | 48,288 | 52,429 | 46,397 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 47,436 | 48,288 | 52,429 | 46,397 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $47,436 | $48,288 | $52,429 | $46,397 |
|
0.50% Nasdaq 0.00%
Income Statement
